(Total Views: 499)
Posted On: 07/31/2020 1:53:12 PM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: bwolfy2002 #46399
Take a deep breath, Primary endpoint isnt the be all end all, particularly if its due to the placebo group improving to a point where we dont have the opportunity to be statistically significant (even if 100% of treatment arm recovered, which is likely)
In a phase 2b/3 you can lean on secondary endpoints. Good data is coming. I dont know how much more clearly Nader can say it (other than publishing the data)
In a phase 2b/3 you can lean on secondary endpoints. Good data is coming. I dont know how much more clearly Nader can say it (other than publishing the data)
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)